Deanna L. Lane, M.D.
Department of Breast Imaging, Division of Diagnostic Imaging
About Dr. Deanna L. Lane
Dr. Deanna L. Lane is a Professor of Diagnostic Radiology in the Department of Breast Imaging at The University of Texas MD Anderson Cancer Center. She obtained her medical degree in 1999 from The University of Texas Health Science Center at Houston Medical School. From 2000-2004, she pursued her residency training in diagnostic radiology at the Medical College of Virginia, followed by a fellowship in breast imaging at MD Anderson. She joined the breast imaging faculty at MD Anderson in 2006. She is board certified in radiology and a member of the Society of Breast Imaging. She is involved in the clinical teaching of residents and fellows, has authored peer-reviewed articles and book chapters on breast imaging topics, and serves as Associate Editor for the journal BMC Cancer.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Imaging techniques for the locoregional staging of breast cancer
Ultrasound assessment of regional lymph nodes in breast cancer patients
Imaging assessment of tumor response to chemotherapy
Clinical Interests
Breast cancer staging
Multimodality breast imaging: Mammography, Tomosynthesis, Ultrasound, MRI
Image-guided breast biopsies and procedures
Education & Training
Degree-Granting Education
| 1999 | The University of Texas Health Science Center at Houston, Houston, Texas, US, MD |
| 1995 | Trinity University, San Antonio, Texas, US, Biology, BS |
Postgraduate Training
| 2005-2006 | Clinical Fellowship, Breast Imaging, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2000-2004 | Clinical Residency, Residency in Diagnostic Radiology, Medical College of Virginia, Richmond, Virginia |
| 1999-2000 | Clinical Internship, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas |
Licenses & Certifications
| 2005 | Texas Medical Board Physician's Permit |
| 2004 | American Board of Radiology |
| 2004 | Virginia Board of Medicine |
| 2003 | North Carolina Medical Board |
Experience & Service
Faculty Academic Appointments
Associate Professor, Diagnostic & Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2020 - 2022
Associate Professor, Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2022
Associate Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2019
Assistant Professor, Diagnostic & Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2007 - 2020
Administrative Appointments/Responsibilities
Director of Trainee Education, Co-Director of Breast Imaging Department Education, Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Fellowship Program Director, Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2024
Fellowship Program Director, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019
Breast Imaging Section Scheduler Director, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2016
Other Professional Positions
Clinical Competency Committee, Department of Diagnostic Interventional Imaging, University of Texas Medical School at Houston, Houston, TX, 2013 - 2016
Intramural Institutional Committee Activities
Reviewer, Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Member, Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Extramural Institutional Committee Activities
Member, COVID Recovery Task Force, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Main Campus Breast Imaging Clinical Rotation Management Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present
Member, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2015
Editorial Activities
Associate Editor, BMC Cancer, 2013 - 2019
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Cryo Imaging. Invited. University of Texas MD Anderson Cancer Center. Houston, Texas, US.
- 2022. Breast cryoablation. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Breast hands-on workshop. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. False positives. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Breast MRI biopsy workshop. Conference. Houston Radiological Society. Houston, TX, US.
- 2012. Locoregional staging of breast cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2010. Differential diagnoses in breast imaging with mammographic-ultrasound correlation. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2010. Screening for breast cancer with bilateral whole breast sonography. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2010. Interesting breast imaging cases. Conference. Houston Radiological Society. Houston, TX, US.
Regional Presentations
- 2020. Imaging after dark: breast emergencies. Conference. Texas Radiological Society 107th Annual Meeting. San Antonio, TX, US.
National Presentations
- 2026. Turning Workforce Challenges into Policy Relevant Research. OnlineOnly. ACR Institute for Radiologic Pathology. Houston, US.
- 2022. Multi-parametric MRI-based radiomics models from tumor and peritumoral regions as potential predictors of treatment response to neoadjuvant systemic therapy in triple negative breast cancer patients (scientific poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2022. Longitudinal DCE-MRI radiomic models for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients (scientific poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2022. DCE-MRI for early prediction of excellent response versus chemoresistance in triple negative breast cancer (scientific poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2022. A pre-operative dynamic contrast enhanced MRI-based radiomics models as predictors of treatment response after neoadjuvant systemic therapy in triple negative breast cancer patients (scientific poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2022. Multi-parametric MRI-based radiomics models for early neoadjuvant systemic treatment response prediction in triple negative breast cancer (TNBC) (scientific poster). Conference. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2022. Early prediction of chemoresistance versus excellent response in triple negative breast cancer patients with DCE-MRI. Conference. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2022. Development of a combined model for early prediction of pathologic complete response (pCR) in triple negative breast cancer (TNBC) undergoing neoadjuvant therapy (NAT). Conference. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2022. Deep learning using pre-treatment MRIs and clinical information for prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer. Conference. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. Deep learning for early prediction of neoadjuvant chemotherapy response in triple negative breast cancers (poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Prediction of response to neoadjuvant systemic therapy in triple negative breast cancer using baseline tumor MRI characteristics and imaging patterns of response (poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Integrated model for early prediction of neoadjuvant systemic therapy response in triple negative breast cancer (spot-light poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Radiomics model based on magnetic resonance image compilation (MagIC) as early predictor of pathologic complete response to neoadjuvant systemic therapy in triple-negative breast cancer (spot-light poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Quantitative molecular breast imaging for early prediction of neoadjuvant systemic therapy response in locally advanced breast cancer patients (poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Immunogenic response and abnormal axillary node morphology in triple negative breast cancer patients (scientific poster). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. Early prediction of chemoresistance versus excellent response in triple negative breast cancer patients (TNBC) with DCE-MRI (scientific poster). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. A thoracic radiologist’s guide to identification and management of mammary findings on chest CT (education exhibit). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. A composite model for pathologic complete response (pCR) prediction in triple negative breast cancer (TNBC) (scientific poster). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. Prediction of pathologic complete response in triple negative breast cancer using baseline tumor MRI characteristics and patterns of response during neoadjuvant chemotherapy (poster). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. Prediction of pathological complete response to neoadjuvant systemic therapy of triple negative breast cancers via deep learning. Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2020. Volumetric changes on longitudinal dynamic contrast enhanced MR imaging (DCE-MRI) as an early treatment response predictor to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients (poster). Conference. San Antonio Breast Cancer Symposium (virtual event). San Antonio, TX, US.
- 2020. Radiomic phenotypes from dynamic contrast-enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients (poster). Conference. San Antonio Breast Cancer Symposium (virtual event). San Antonio, TX, US.
- 2020. Assessment of early response to neoadjuvant systemic therapy (NAST) of triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: a pilot study (poster). Conference. San Antonio Breast Cancer Symposium (virtual event). San Antonio, TX, US.
- 2020. Assessment of early response to neoadjuvant systemic therapy (NAST) in triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: pilot study (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Comparison of chemical exchange saturation transfer (CEST) MRI acquisition and analysis for early neoadjuvant systemic therapy (NAST) treatment response assessment in triple negative breast cancer (TNBC) (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Radiomic phenotypes from ultrafast dynamic contrast enhanced (DCE) MRI for prediction of the treatment response to neoadjuvant systemic therapy (NAST) of triple negative breast cancer (TNBC) (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. BI-RADS ultrasound lexicon descriptors and tumor-infiltrating lymphocytes in triple negative breast cancer. Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. High risk breast cancer screening (education exhibit). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Longitudinal MR imaging findings in triple negative breast cancer (TNBC) patients undergoing neoadjuvant systemic therapy (NAST) stratified by tumor infiltrating lymphocytes (TIL) levels (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Reliability of pharmacokinetic (PK) parameters by DCE-MRI for prediction of neoadjuvant systemic treatment (NAST) response in triple negative breast cancer (TNBC) patients: a comparison of three analysis methods (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Radiomic features of quantitative apparent diffusion coefficient (ADC) maps from peritumoral regions (PTRs) as predictors of early treatment response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2019. Quantitative apparent diffusion coefficient (ADC) radiomics of tumor and peritumoral regions as potential predictors of treatment response to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC) patients. Conference. Forty-second Annual CTRC-AACR San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2019. Radiomics of quantitative apparent diffusion coefficient (ADC) from fibroglandular tissue (FGT) for prediction of tumor infiltrating lymphocytes (TIL) levels and neoadjuvant chemotherapy treatment (NACT) response in triple negative breast cancer (TNBC). Conference. Forty-second Annual CTRC-AACR San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2019. Predicting pathologic complete response with ultrasound tumor characteristics in triple negative breast cancer patients. Conference. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2019. Precision imaging: early ultrasound evaluation (US) to identify excellent responders to neoadjuvant chemotherapy (NAC) in patients (pts) with triple negative breast cancer (TNBC). Conference. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2019. Quantitative tumor volumes by fast dynamic contrast enhanced (DCE) MRI predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC). Conference. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2019. Tumor necrosis at baseline dynamic contrast enhanced (DCE) MRI for prediction of neoadjuvant chemotherapy treatment (NACT) response in triple negative breast cancer (TNBC) patients. Conference. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2019. Precision imaging: early ultrasound evaluation (US) identifies excellent responders to neoadjuvant chemotherapy (NAC) in patients (pts) with triple negative breast cancer (TNBC). Conference. American Society of Clinical Oncology. Chicago, IL, US.
- 2018. Early ultrasound evaluation for prediction of treatment response to neoadjuvant chemotherapy in triple negative breast cancer patients (poster). Conference. Forty-first Annual CTRC-AACR San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2018. Do triple negative breast cancers have characteristic imaging features according to androgen receptor and vimentin status?. Conference. 104th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2018. Can mid-treatment ultrasound in triple negative breast cancer patients predict residual pathologic disease in the axillary nodes?. Conference. 104th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2018. Impact of metaplastic histology (MpBC) in triple-negative breast cancer (TNBC) patients (pts) receiving neoadjuvant systemic therapy (NAST). Conference. American Society of Clinical Oncology. Chicago, IL, US.
- 2018. A sheep in wolf's clothing - imaging assessment of multiple intraductal breast papillomas. Conference. 118th American Roentgen Ray Society Annual Meeting. Washington, DC, US.
- 2016. Breast MRI guided biopsy workshop. Invited. 102nd Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2016. Synthesized mammography (SM) versus full field digital mammography (FFDM): a comparison of lesion detection by radiologists. Conference. 102nd Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2016. Computer-aided detection (CAD) for synthesized mammography: does it perform the same as CAD for full-field digital mammography?. Conference. 102nd Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
International Presentations
- 2018. Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC). Conference. European Society for Medical Oncology. Munich, DE.
- 2015. Approach to diagnosis: a case based imaging review. Invited. 115th American Roentgen Ray Society Annual Meeting. Toronto, CA.
- 2014. Multidisciplinary cases discussion of breast lesions. Invited. Precongress workshop for IAP congress 2014, "Surviving Early Years in Practice". Bangkok, TH.
Selected Publications
Peer-Reviewed Articles
- Huo, X, Moseley, T, Adrada, BE, Yam, C, Huo, L, Guirguis, MS, Patel, MM, Leung, J, Whitman, GJ, Candelaria, RP, Lane, DL, Yang, WT, Sun, J, Litton, J, Valero, V, Arun, BK, Hwang, K, Wei, P, Ma, J, Rauch, GM. DCE-MRI for assessment of pathologic complete response after completion of neoadjuvant therapy in triple-negative breast cancer patients. Journal of Clinical Oncology 44:611, 2026. e-Pub 2026.
- Adrada, BE, Guirguis, MS, Huo, L, Yam, C, Tripathy, D, Candelaria, RP, Yang, W, Patel, MM, Moseley, T, Whitman, GJ, Leung, J, Le-Petross, H, Lane, DL, Abuhadra, NK, Litton, J, Valero, V, Hunt, KK, Arun, BK, Mohamed, R, Sun, J, Korkut, A, Pashapoor, S, White, JB, Thompson, A, Wei, P, Ma, J, Moulder, S, Rauch, GM. Erratum Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer. JCO Precis Oncol 10(5), 2026. e-Pub 2026. PMID: 42150150.
- Huang ML, Lane DL, Chang Sen LQ, Candelaria RP, Santiago L. Postcryoablation Breast Imaging Algorithms, Findings, and Standardized Reporting. J Breast Imaging 8(1):96-108, 2026. e-Pub 2026. PMID: 41558639.
- Guirguis MS, Adrada BE, Yam C, Tripathy D, Candelaria R, Yang W, Patel M, Moseley T, Perez F, Whitman GJ, Leung JWT, Le-Petross H, Lane DL, Huo L, Litton JK, Valero V, Hunt KK, Arun B, Mohamed R, Sun J, Korkut A, Xu Z, Pashapoor S, White J, Son JB, Thompson A, Wei P, Ma J, Moulder S, Rauch GM. Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer. NPJ Breast Cancer 11(1):129, 2025. e-Pub 2025. PMID: 41266347.
- Adrada BE, Guirguis MS, Huo L, Yam C, Tripathy D, Candelaria R, Yang W, Patel M, Moseley T, Whitman GJ, Leung JWT, Le-Petross H, Lane DL, Abuhadra N, Litton J, Valero V, Hunt KK, Arun B, Mohamed R, Sun J, Korkut A, Pashapoor S, White J, Thompson A, Wei P, Ma J, Moulder S, Rauch GM. Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer. JCO Precis Oncol 9:e2500410, 2025. e-Pub 2025. PMID: 41411609.
- Xu Z, Zhou Z, Son JB, Feng H, Adrada BE, Moseley TW, Candelaria RP, Guirguis MS, Patel MM, Whitman GJ, Leung JWT, Le-Petross HTC, Mohamed RM, Panthi B, Lane DL, Chen H, Wei P, Tripathy D, Litton JK, Valero V, Huo L, Hunt KK, Korkut A, Thompson A, Yang W, Yam C, Rauch GM, Ma J. Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer. Cancers (Basel) 17(6), 2025. e-Pub 2025. PMID: 40149299.
- Huang ML, Lane DL, Chang Sen LQ, Candelaria RP, Kuerer HM, Hunt KK, Akay C, Lim B, Shaitelman S, Hwang RF, Chen H, Katta R, Santiago L. Defining Breast Cryoablation Treatment Success: A Guide for the Curative and Palliative Treatment of Breast Cancer. Acad Radiol 31(12):4759-4771, 2024. e-Pub 2024. PMID: 39107186.
- Huang ML, Lane DL, Bomar H, Kuerer H. Breast cryoablation for the palliative treatment of indolent subtype of multicentric triple-negative breast cancer. BMJ Case Rep 17(4), 2024. e-Pub 2024. PMID: 38627044.
- Huang ML, Lane DL, Santiago L. MRI-Guided Breast Cryoablation With the Patient in Prone Position. AJR Am J Roentgenol 222(4):e2330754, 2024. e-Pub 2024. PMID: 38353451.
- Xu Z, Rauch DE, Mohamed RM, Pashapoor S, Zhou Z, Panthi B, Son JB, Hwang KP, Musall BC, Adrada BE, Candelaria RP, Leung JWT, Le-Petross HTC, Lane DL, Perez F, White J, Clayborn A, Reed B, Chen H, Sun J, Wei P, Thompson A, Korkut A, Huo L, Hunt KK, Litton JK, Valero V, Tripathy D, Yang W, Yam C, Ma J. Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835523.
- Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yam C, Boge M, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Mohamed RM, Musall BC, Pashapoor S, Patel MM, Perez F, Son JB, Thompson A, Valero V, Wei P, White J, Xu Z, Pinsky L, Tripathy D, Yang W, Ma J, Rauch GM. Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. Cancers (Basel) 15(4), 2023. e-Pub 2023. PMID: 36831368.
- Echeverria GV, Cai S, Tu Y, Shao J, Powell E, Redwood AB, Jiang Y, McCoy A, Rinkenbaugh AL, Lau R, Trevarton AJ, Fu C, Gould R, Ravenberg EE, Huo L, Candelaria R, Santiago L, Adrada BE, Lane DL, Rauch GM, Yang WT, White JB, Chang JT, Moulder SL, Symmans WF, Hilsenbeck SG, Piwnica-Worms H. Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer. NPJ Breast Cancer 9(1):2, 2023. e-Pub 2023. PMID: 36627285.
- Panthi B, Mohamed RM, Adrada BE, Boge M, Candelaria RP, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Pashapoor S, Perez F, Son JB, Sun J, Thompson A, Tripathy D, Valero V, Wei P, White J, Xu Z, Yang W, Zhou Z, Yam C, Rauch GM, Ma J. Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Front Oncol 13:1264259, 2023. e-Pub 2023. PMID: 37941561.
- Kilgore LJ, Yi M, Bevers T, Coyne R, Lazzaro M, Lane D, Albarracin C, Bedrosian I. Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision. Ann Surg 276(6):E932-E936, 2022. e-Pub 2022. PMID: 33914469.
- Candelaria RP, Adrada BE, Lane DL, Rauch GM, Moulder SL, Thompson AM, Bassett RL, Arribas EM, Le-Petross HT, Leung JWT, Spak DA, Ravenberg EE, White JB, Valero V, Yang WT. Midtreatment ultrasound descriptors as qualitative imaging biomarkers of pathologic complete response in patients with triple negative breast cancer. Ultrasound Med Biol 48(6):1010-1018, 2022. e-Pub 2022. PMID: 35300879.
- Omofoye TS, Leong LCH, Kalambo M, Teo SY, Lim WEH, Chew DCY, Lee SYS, Lane D, Kapoor MM, Martaindale S, Teichgraeber D, Moseley T, Phalak K, Srinivasan A, Sun J, Whitman G, Leung JWT, Tan BS, Yang WT. Responsive web-based breast imaging core curriculum for international radiology residents with self-assessment: a pilot study. Acad Radiol 29(6):919-927, 2022. e-Pub 2022. PMID: 34389260.
Review Articles
- Huang ML, Tomkovich K, Lane DL, Katta R, Candelaria RP, Santiago L. Breast Cancer Cryoablation Fundamentals Past and Present: Technique Optimization and Imaging Pearls. Acad Radiol 30(10):2383-2395, 2023. e-Pub 2023. PMID: 37455177.
Abstracts
- Rauch GM, Adrada BE, Guirguis MS, Patel MM, Candelaria RP, Mohamed RM, Moseley TW, Le Petross HT, Leung JWT, Whitman GJ, Lane DL, Marion Scoggins M, Perez F, Sun J, Pashapoor S, Xu Z, White JB, Wei P, Reed B, Son JB, Hwang KP, Panthi B, Korku A, Huo L, Hunt KK, Clayborn A, Litton JK, Valero V, Tripathy D, Yang WT, MA J, Yam C. Early prediction of response to neoadjuvant immunotherapy in triple negative breast cancer (tnbc) with dce-mri, 2023. e-Pub 2023.
- Guirguis MS, Adrada B, Patel M, Perez F, Candelaria R, Yang WT, Sun J, Mohamed RM, Boge M, Le-Petross HTC, Leung JWT, Whitman GJ, Lane DL, Scoggins ME, Moseley T, White J, Wei P, Son JB, K-P H, Panthi B, Pagel M, Hunt KK, Thompson AM, Litton JK, Valero V, Tripathy D, Yam C, Ma J, Rauch G. DCE-MRI for early prediction of excellent response versus chemoresistance in triple negative breast cancer. Cancer Res 83(5 suppl), 2023. e-Pub 2023.
- Panthi B, Mohamed RM, Adrada BE, Candelaria R, Guirguis MS, Yang WT, Boge M, Patel M, Elshafeey N, Pashapoor S, Zhou Z, Son JB, K-P H, Le-Petross HTC, Leung JWT, Scoggins ME, Whitman GJ, Xu Z, Lane DL, Moseley T, Perez F, White J, Ravenberg E, Clayborn A, Pagel M, Chen H, Sun J, Wei P, Thompson AM, Moulder S, Korkut A, Huo L, Hunt KK, Litton JK, Valero V, Tripathy D, Yam C, Rauch G. Longitudinal DCE-MRI radiomic models for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients. Cancer Res 83(5 suppl), 2023. e-Pub 2023.
- Guirguis MS, Adrada BE, Patel M, Perez F, Candelaria RP, Yang WT, Sun J, Mohamed RMM, Boge M, Le-Petross HC, Leung JWT, Whitman GJ, Lane DL, Scoggins ME, Moseley TW, Musall B, White J, Zhou Z, Pashapoor S, Wei P, Son JB, K-P H, Panthi B, Pagel MD, Huo L, Hunt KK, Ravenberg E, Thompson A, Litton J, Valero V, Tripathy D, Moulder S, Yam C, Ma J, Rauch GM. Early prediction of chemoresistance versus excellent response in triple negative breast cancer patients with DCE-MRI. Cancer Res 83(5 suppl), 2023. e-Pub 2023.
- Mohamed RM, Panthi B, Adrada BE, Candelaria R, Guirguis MS, Yang WT, Boge M, Patel M, Elshafeey N, Pashapoor S, Zhou Z, Son JB, K-P H, Le-Petross HTC, Leung JWT, Scoggins ME, Whitman GJ, Xu Z, Lane DL, Moseley T, Perez F, White J, Ravenberg E, Clayborn A, Pagel M, Chen H, Sun J, Wei P, Thompson AM, Moulder S, Korkut A, Huo L, Hunt KK, Litton JK, Valero V, Tripathy D, Yam C, Ma J, Rauch G. Multi-parametric MRI-based radiomics models from tumor and peritumoral regions as potential predictors of treatment response to neoadjuvant systemic therapy in triple negative breast cancer patients. Cancer Res 83(5 suppl), 2023. e-Pub 2023.
- Mohamed RM, Panthi B, Adrada BE, Candelaria R, Guirguis MS, Yang WT, Boge M, Patel M, Elshafeey N, Pashapoor S, Zhou Z, Son JB, K-P H, Le-Petross HTC, Leung JWT, Scoggins ME, Whitman GJ, Xu Z, Lane DL, Moseley T, Perez F, White J, Chen H, Sun J, Wei P, Litton JK, Valero V, Yam C, Pagel M, Ma J, Rauch G. A pre-operative dynamic contrast enhanced MRI-based radiomics models as predictors of treatment response after neoadjuvant systemic therapy in triple negative breast cancer patients. Cancer Res 83(5 suppl), 2022. e-Pub 2022.
- Zhou Z, Adrada BE, Candelaria RP, Mohamed RM, Pashapoor S, Panthi B, Son JB, Xu Z, Hwang KP, Guirguis MS, Yang WT, Whitman GJ, Lane DL, Le-Petross HC, Leung JWT, Moseley T, Scoggins ME, Patel MM, Perez F, White J, Litton J, Valero V, Tripathy D, Yam C, Pagel MD, Ma J, Rauch GM. Deep learning using pre-treatment MRIs and clinical information for prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America, 2022. e-Pub 2022.
- Adrada BE, Guirguis MS, Patel MM, Perez F, Candelaria RP, Yang WT, Sun J, Mohamed RM, Boge M, Le-Petross HC, Leung JWT, Whitman GJ, Lane DL, Scoggins ME, Moseley T, Musall B, White J, Zhou Z, Wei P, Son JB, K-P H, Panthi B, Pagel M, Huo L, Hunt K, Ravenberg E, Thompson A, Litton J, Valero V, Tripathy D, Moulder S, Yam C, Ma J, Rauch GM. Development of a combined model for early prediction of pathologic complete response (pCR) in triple negative breast cancer (TNBC) undergoing neoadjuvant therapy (NAT). 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America, 2022. e-Pub 2022.
- Mohamed RM, Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yang WT, Boge M, Patel MM, Elshafeey NA, Pashapoor S, Zhou Z, Son JB, K-P H, Le-Petross HC, Leung JWT, Scoggins ME, Whitman GJ, Xu Z, Lane DL, Moseley TW, Perez F, White J, Chen H, Sun J, Wei P, Litton J, Valero V, Tripathy D, Yam C, Pagel MD, Ma J, Rauch GM. Multi-parametric MRI-based radiomics models for early neoadjuvant systemic treatment response prediction in triple negative breast cancer (TNBC). 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America, 2022. e-Pub 2022.
Patient Reviews
CV information above last modified August 20, 2026